Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 563681 - 563700 out of 563771 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA (VA) | (L01EA02) dasatinib (adm: O) | DASATINIB 140MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA (VA) | (L01EA02) dasatinib (adm: O) | DASATINIB 20MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA (VA) | (L01EA02) dasatinib (adm: O) | DASATINIB 50MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA (VA) | (L01EA02) dasatinib (adm: O) | DASATINIB 70MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA (VA) | (L01EA02) dasatinib (adm: O) | DASATINIB 80MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA (VA) | (L01EA06) asciminib (adm: O) | SCEMBLIX 100MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NovartisPharmaceuticalsCorporation |
| USA (VA) | (L01EH04) zongertinib | HERNEXEOS 60MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA (VA) | (L01EH04) zongertinib | HERNEXEOS 60MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 11MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 11MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 22MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 22MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 33MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 33MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 44MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 44MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 55MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ01) ruxolitinib (adm: O) | JAKAFI XR 55MG | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | IncyteCorporation |
| USA (VA) | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
| USA (VA) | (L01EJ03) pacritinib | VONJO 100MG CAP | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Sobi,Inc. |
Pages
